This site makes use of Javascript, please enable your web browser to allow Javascript. Thank you.

Individual Liability in the Drug and Device Sectors and the Resurgence of the Park Doctrine…

March 17, 2011

Michael A. Rogoff, Co-Chair of the Complex Commercial Litigation Department and Chair of the White Collar Litigation and Internal Investigations group conducted a one-hour webcast titled “Individual Liability in the Drug and Device Sectors and the Resurgence of the Park Doctrine” at 1:00 p.m. ET on March 17, 2011.

Recently, the U.S. government has increasingly focused on individual accountability in the drug and device sectors. As a result, pharmaceutical and medical device manufacturers need to understand the new enforcement climate and assess their risks and compliance systems.

Topics covered in the webcast included:

  • Recent individual prosecutions in the drug and device sector
  • The “Responsible Corporate Officer” or Park Doctrine: Where it comes from and how it is now being used
  • Recent CIA certification requirements and OIG guidance on the exclusion of individuals
  • FDA guidance on individual Park-based prosecutions
  • Guidance on how drug and device companies and their employees could address the risks posed by the Park doctrine

March 17, 2011